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Supplementary figure 1. Passing-Bablok regression between serum F and salivary F (A: y=0.02x+0.04, r=0,72, p<0.001) and E (B: y=0.08x+1.17, r=0,73, p<0.001) 1 
in patients with central AI, for both basal and post-synacthen samples (n=74). 2 
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Supplementary figure 2. Passing-Bablok regression between serum F and salivary F (A: y=0.06x-0.70, r=0.71, p<0.001) and E (B: y=0.11x-4.02, r=0.67, p<0.001) 6 
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Supplementary figure 3. Passing-Bablok regression between serum F and salivary F (A: y=0.07x-12.71, r=0.66, p<0.001) and E (B: y=0.13x-6.39, r=0.70, p<0.001) 12 
in patients with a normal HPA axis, for both basal and post-synacthen samples (n=212) 13 
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Supplementary figure 4: Distribution of patients by our calculated threshold for salivary cortisol (F). 17 
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